Literature DB >> 8948644

Interstrand cross-linking reaction in triplexes containing a monofunctional transplatin-adduct.

C Colombier1, B Lippert, M Leng.   

Abstract

Our aim was to determine whether a single transplatin monofunctional adduct, either trans-[Pt(NH3)2(dC)Cl]+ or trans-[Pt(NH3)2(dG)Cl]+ within a homopyrimidine oligonucleotide, could further react and form an interstrand cross-link once the platinated oligonucleotide was bound to the complementary duplex. The single monofunctional adduct was located at either the 5' end or in the middle of the platinated oligonucleotide. In all the triplexes, specific interstrand cross-links were formed between the platinated Hoogsteen strand and the complementary purine-rich strand. No interstrand cross-links were detected between the platinated oligonucleotides and non-complementary DNA. The yield and the rate of the cross-linking reaction depend upon the nature and location of the monofunctional adducts. Half-lives of the monofunctional adducts within the triplexes were in the range 2-6 h. The potential use of the platinated oligonucleotides to modulate gene expression is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8948644      PMCID: PMC146263          DOI: 10.1093/nar/24.22.4519

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  19 in total

1.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

2.  Optimization of the efficiency of cross-linking PtII oligonucleotide phosphorothioate complexes to complementary oligonucleotides.

Authors:  B C Chu; L E Orgel
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

3.  [Epidemiological analysis of the influenza virus A carrier state in healthy children].

Authors:  L S Karpova; T L Popova; N A Ivanova; E A Zibina; V L Ivanova
Journal:  Vopr Virusol       Date:  1983 May-Jun

4.  Distortions induced in double-stranded oligonucleotides by the binding of cis- or trans-diammine-dichloroplatinum(II) to the d(GTG) sequence.

Authors:  M F Anin; M Leng
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

5.  Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA.

Authors:  M A Lemaire; A Schwartz; A R Rahmouni; M Leng
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

6.  Interaction of trans-diamminedichloroplatinum(II) with DNA: formation of monofunctional adducts and their reaction with glutathione.

Authors:  A Eastman; M A Barry
Journal:  Biochemistry       Date:  1987-06-16       Impact factor: 3.162

7.  An efficient, sequence-specific method for crosslinking complementary oligonucleotides using binuclear platinum complexes.

Authors:  E S Gruff; L E Orgel
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

8.  Identification and characterization of a novel linkage isomerization in the reaction of trans-diamminedichloroplatinum(II) with 5'-d(TCTACGCGTTCT).

Authors:  K M Comess; C E Costello; S J Lippard
Journal:  Biochemistry       Date:  1990-02-27       Impact factor: 3.162

Review 9.  Nucleic acid hybridization: triplex stability and energetics.

Authors:  G E Plum; D S Pilch; S F Singleton; K J Breslauer
Journal:  Annu Rev Biophys Biomol Struct       Date:  1995

10.  Stable triple helices formed by oligonucleotide N3'-->P5' phosphoramidates inhibit transcription elongation.

Authors:  C Escudé; C Giovannangeli; J S Sun; D H Lloyd; J K Chen; S M Gryaznov; T Garestier; C Hélène
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

View more
  9 in total

1.  Factors influencing the extent and selectivity of alkylation within triplexes by reactive G/A motif oligonucleotides.

Authors:  J N Lampe; I V Kutyavin; R Rhinehart; M W Reed; R B Meyer; H B Gamper
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

2.  Probing platinum-adenine-n3 adduct formation with DNA minor-groove binding agents.

Authors:  Lu Rao; Tiffany K West; Gilda Saluta; Gregory L Kucera; Ulrich Bierbach
Journal:  Chem Res Toxicol       Date:  2010-07-19       Impact factor: 3.739

3.  Transplatin-conjugated triplex-forming oligonucleotides form adducts with both strands of DNA.

Authors:  Meghan A Campbell; Paul S Miller
Journal:  Bioconjug Chem       Date:  2009-12       Impact factor: 4.774

4.  Cross-linking to an interrupted polypurine sequence with a platinum-modified triplex-forming oligonucleotide.

Authors:  Meghan A Campbell; Paul S Miller
Journal:  J Biol Inorg Chem       Date:  2009-04-07       Impact factor: 3.358

5.  Inhibition of transcription by platinated triplex-forming oligonucleotides.

Authors:  Mindy K Graham; Paul S Miller
Journal:  J Biol Inorg Chem       Date:  2012-09-11       Impact factor: 3.358

6.  A Click Chemistry Approach to Targeted DNA Crosslinking with cis-Platinum(II)-Modified Triplex-Forming Oligonucleotides.

Authors:  Joseph Hennessy; Bríonna McGorman; Zara Molphy; Nicholas P Farrell; Daniel Singleton; Tom Brown; Andrew Kellett
Journal:  Angew Chem Int Ed Engl       Date:  2021-12-03       Impact factor: 16.823

7.  Palladacyclic Conjugate Group Promotes Hybridization of Short Oligonucleotides.

Authors:  Madhuri Hande; Sajal Maity; Tuomas Lönnberg
Journal:  Int J Mol Sci       Date:  2018-05-28       Impact factor: 5.923

8.  2-Trifluoromethyl-6-mercurianiline Nucleotide, a Sensitive 19F NMR Probe for Hg(II)-mediated Base Pairing.

Authors:  Asmo Aro-Heinilä; Assi Lepistö; Antti Äärelä; Tuomas Antti Lönnberg; Pasi Virta
Journal:  J Org Chem       Date:  2021-12-14       Impact factor: 4.354

9.  Different Effects of Cisplatin and Transplatin on the Higher-Order Structure of DNA and Gene Expression.

Authors:  Toshifumi Kishimoto; Yuko Yoshikawa; Kenichi Yoshikawa; Seiji Komeda
Journal:  Int J Mol Sci       Date:  2019-12-19       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.